Mathur Amit K, Nadig Satish N, Kingman Stephanie, Lee Dustin, Kinkade Kathleen, Sonnenday Christopher J, Welling Theodore H
Division of Transplant Surgery, Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ, USA; Mayo Clinic Robert D. and Patricia E. Kern Center for Science of Health Care Delivery, Charleston, SC, USA.
Clin Transplant. 2015 Apr;29(4):327-35. doi: 10.1111/ctr.12518. Epub 2015 Feb 23.
Biliary complications are a leading source of surgical morbidity following orthotopic liver transplantation (OLT).
We examined how prophylactic internal biliary stent placement during OLT affected post-transplant morbidity and mortality in a single-center retrospective cohort study of 513 recipients (2006-2012). Recipient and donor covariates were collected. Biliary complications included major and minor anastomotic leaks, strictures, or stenoses. Multivariate regression models were created to estimate how operative biliary stents affected outcomes.
About 87.3% (n = 448) of recipients had a duct-to-duct biliary anastomosis, and 43.1% (n = 221) had biliary stents placed. The biliary complication rate was <15% at five yr, and 44.8% (n = 230) overall. Stenting was not protective from anastomotic biliary complications (p = 0.06). Stenting was associated with a 74% higher adjusted risk of needing multiple endoscopic retrograde cholangiographies (ERCs; odds ratio [OR] 1.74, p = 0.011), and trended toward a lower adjusted risk for repetitive percutaneous transhepatic cholangiography (PTCs; OR 0.56, p = 0.063). Stenting had no effect on the cumulative freedom from biliary complications (p = 0.94). Biliary complications were associated with mortality (HR 1.86, p = 0.014) and was unaffected by stenting (aHR = 0.72, p = 0.246).
Biliary stenting during OLT does not deter biliary complications and is associated with higher risk of multiple invasive biliary interventions, particularly ERCs. Surgeons should evaluate the utility of biliary stents at OLT within this context.
胆道并发症是原位肝移植(OLT)术后手术发病的主要原因。
在一项对513例受者(2006 - 2012年)的单中心回顾性队列研究中,我们研究了OLT期间预防性放置胆道内支架如何影响移植后发病率和死亡率。收集了受者和供者的协变量。胆道并发症包括主要和次要的吻合口漏、狭窄或狭窄。建立多变量回归模型以估计术中胆道支架如何影响结局。
约87.3%(n = 448)的受者进行了胆管对胆管的胆道吻合,43.1%(n = 221)放置了胆道支架。5年时胆道并发症发生率<15%,总体发生率为44.8%(n = 230)。支架置入不能预防吻合口胆道并发症(p = 0.06)。支架置入与需要多次内镜逆行胆管造影(ERC)的校正风险高74%相关(比值比[OR] 1.74,p = 0.011),且有降低重复经皮经肝胆管造影(PTC)校正风险的趋势(OR 0.56,p = 0.063)。支架置入对胆道并发症的累积无发生率无影响(p = 0.94)。胆道并发症与死亡率相关(HR 1.86,p = 0.014),且不受支架置入影响(校正后HR = 0.72,p = 0.246)。
OLT期间的胆道支架置入不能阻止胆道并发症的发生,且与多次侵入性胆道干预尤其是ERC的较高风险相关。在此背景下,外科医生应评估OLT时胆道支架的效用。